Deva Pharmaceuticals

Deva is a leading Turkish pharmaceutical company that develops, manufactures, and markets a wide range of generic medicines, active pharmaceutical ingredients (APIs), and veterinary products. Founded in 1958 and headquartered in Istanbul, the company operates state-of-the-art, EU-GMP certified production facilities and maintains a robust R&D center focused on complex generics and biosimilars. Deva's extensive product portfolio spans numerous therapeutic areas, including oncology, cardiology, respiratory, and ophthalmology, with exports reaching over 50 countries. As a subsidiary of EastPharma, Deva is publicly traded on the Borsa Istanbul and is recognized as one of the largest players in the Turkish healthcare market. The company continues to expand its global footprint through its international brand, Devatis, focusing on highly regulated markets like the US and Europe. Deva is also notable for being the first company in Turkey to receive a biosimilar production license.